You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Related Complications & Care Videos on Diabetes Health TV
Surgeon's Skin Secret
New Small Molecule Drugs for Type 2 - Human Trials Underway
Doctor's Choice® - Advanced Wound Care - Bandages and Dressings Designed for Diabetes Patients
Popular Black Box Warning Articles
Highly Recommended Black Box Warning Articles
The Food and Drug Administration has approved US sale of generic pioglitazone (trade name Actos) for the treatment of type 2 diabetes. Actos, originally developed and trademarked by Takeda Pharmaceuticals, works by decreasing insulin resistance in type 2 patients. The prescription drug, which belongs to the class of drugs known as thiazolidinediones (TZDs), has enjoyed great commercial success in the United States since its introduction in 1999, posting estimated sales last year of $2.7 billion.
0 comments - Aug 27, 2012 -
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.